Correlation Between Eyenovia and Seres Therapeutics

Can any of the company-specific risk be diversified away by investing in both Eyenovia and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eyenovia and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eyenovia and Seres Therapeutics, you can compare the effects of market volatilities on Eyenovia and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eyenovia with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eyenovia and Seres Therapeutics.

Diversification Opportunities for Eyenovia and Seres Therapeutics

0.24

Correlation Coefficient

Eyenovia  Seres Therapeutics

Modest diversification

The 3 months correlation between Eyenovia and Seres is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Eyenovia and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and Eyenovia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eyenovia are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of Eyenovia i.e., Eyenovia and Seres Therapeutics go up and down completely randomly.

Pair Corralation between Eyenovia and Seres Therapeutics

Given the investment horizon of 90 days Eyenovia is expected to under-perform the Seres Therapeutics. In addition to that, Eyenovia is 1.83 times more volatile than Seres Therapeutics. It trades about -0.12 of its total potential returns per unit of risk. Seres Therapeutics is currently generating about 0.09 per unit of volatility. If you would invest  78.00  in Seres Therapeutics on September 3, 2024 and sell it today you would earn a total of  20.00  from holding Seres Therapeutics or generate 25.64% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Eyenovia  vs.  Seres Therapeutics

Eyenovia

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Eyenovia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Seres Therapeutics

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Seres Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Seres Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Eyenovia and Seres Therapeutics

The main advantage of trading using opposite Eyenovia and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eyenovia position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.

The idea behind Eyenovia and Seres Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.